Matrix metalloproteinases increase very early during experimental focal cerebral ischemia

被引:491
作者
Heo, JH [1 ]
Lucero, J [1 ]
Abumiya, T [1 ]
Koziol, JA [1 ]
Copeland, BR [1 ]
del Zoppo, GJ [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
matrix metalloproteinase; cerebral ischemia; zymography; neuron injury; hemorrhagic transformation; basal lamina;
D O I
10.1097/00004647-199906000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microvascular integrity is lost during focal cerebral ischemia. The degradation of the basal lamina and extracellular matrix are, in part, responsible for the loss of vascular integrity. Matrix metalloproteinases (MMPs) may play a pri mary role in basal lamina degradation. By using a sensitive modification of gelatin zymography, the authors investigated the activity of MMP-2 and MMP-9 in frozen 10-mu m sections of ischemic and nonischemic basal ganglia and plasma samples of 27 non-human primates after middle cerebral artery occlusion/ reperfusion (MCAO/R) for various periods. The gelatinolytic activities were compared with parallel cell dUTP incorporation in the ischemic zones of adjacent sections. In the brain, the integrated density of MMP-2 increased significantly by 1 hour after MCAO and was persistently elevated thereafter. Matrix metalloproteinase-2 expression was highly correlated with the extent of neuron injury and the number of injured neurons (r = 0.9763, SE = 0.004,2P < 0.0008). Matrix metalloproteinase-9 expression only was significantly increased in subjects with hemorrhagic transformation. In plasma, only MMP-9 increased transiently at 2 hours of MCAO. These findings highlight the early potential role of MMP-2 in the degradation of basal lamina leading to neuronal injury, and an association of MMP-9 with hemorrhagic transformation after focal cerebral ischemia.
引用
收藏
页码:624 / 633
页数:10
相关论文
共 50 条
[1]   Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke [J].
Anthony, DC ;
Ferguson, B ;
Matyzak, MK ;
Miller, KM ;
Esiri, MM ;
Perry, VH .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) :406-415
[2]  
AUMAILLEY M, 1995, KIDNEY INT, V47, pS4
[3]   Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter [J].
Bian, JH ;
Sun, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6330-6338
[4]   Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia [J].
Clark, AW ;
Krekoski, CA ;
Bou, SS ;
Chapman, KR ;
Edwards, DR .
NEUROSCIENCE LETTERS, 1997, 238 (1-2) :53-56
[5]   The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution [J].
Cuzner, ML ;
Gveric, D ;
Strand, C ;
Loughlin, AJ ;
Paemen, L ;
Opdenakker, G ;
Newcombe, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) :1194-1204
[6]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[7]   HEMORRHAGIC TRANSFORMATION FOLLOWING TISSUE PLASMINOGEN-ACTIVATOR IN EXPERIMENTAL CEREBRAL INFARCTION [J].
DELZOPPO, GJ ;
COPELAND, BR ;
ANDERCHEK, K ;
HACKE, W ;
KOZIOL, JA .
STROKE, 1990, 21 (04) :596-601
[8]   EXPERIMENTAL ACUTE THROMBOTIC STROKE IN BABOONS [J].
DELZOPPO, GJ ;
COPELAND, BR ;
HARKER, LA ;
WALTZ, TA ;
ZYROFF, J ;
HANSON, SR ;
BATTENBERG, E .
STROKE, 1986, 17 (06) :1254-1265
[9]  
DELZOPPO GJ, 1995, THROMB THER AC ISCH, P254
[10]   POLYMORPHONUCLEAR LEUKOCYTE BEHAVIOR IN A NONHUMAN PRIMATE FOCAL ISCHEMIA MODEL [J].
EMBER, JA ;
DELZOPPO, GJ ;
MORI, E ;
THOMAS, WS ;
COPELAND, BR ;
HUGLI, TE .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (06) :1046-1054